Optimizing the Antibiotic Treatment of Uncomplicated Acute Appendicitis

NAActive, not recruitingINTERVENTIONAL
Enrollment

552

Participants

Timeline

Start Date

April 3, 2017

Primary Completion Date

November 27, 2018

Study Completion Date

April 1, 2029

Conditions
Acute Appendicitis
Interventions
DRUG

Ertapenem

I.v. ertapenem 1 g for 2 days followed by p.o. levofloxacin 500 mg x1 and metronidazole 500 mg x 3 for 5 days

DRUG

Moxifloxacin

P.o. moxifloxacin 400 mg x1 for 7 days

Trial Locations (1)

Unknown

Turku University Hospital, Turku

All Listed Sponsors
collaborator

Oulu University Hospital

OTHER

collaborator

Tampere University Hospital

OTHER

collaborator

Kuopio University Hospital

OTHER

collaborator

Mikkeli Central Hospital

OTHER

collaborator

Lapland Central Hospital

UNKNOWN

collaborator

Jyväskylä Central Hospital

OTHER

collaborator

Satakunta Central Hospital

OTHER

collaborator

Seinajoki Central Hospital

OTHER

lead

Turku University Hospital

OTHER_GOV

NCT03236961 - Optimizing the Antibiotic Treatment of Uncomplicated Acute Appendicitis | Biotech Hunter | Biotech Hunter